ArticlePharmaceuticals (Basel, Switzerland)2025

In Vitro Characterization of the Published Glypican-3-Targeting Peptide TJ12P2 Reveals a Lack of Specificity and Potency.

Eva-Maria Burger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.